Peptide 021

From Wikipedia, the free encyclopedia

CAS Number
FormulaC27H42N6O8
Molar mass578.667 g·mol−1
Peptide 021
Identifiers
  • (3S)-3-acetamido-4-[[2-[[2-[[(2S)-1-[[(5S,7R)-3-carbamoyl-1-adamantyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid
CAS Number
PubChem CID
Chemical and physical data
FormulaC27H42N6O8
Molar mass578.667 g·mol−1
3D model (JSmol)
  • CC(C)C[C@@H](C(=O)NC12C[C@@H]3C[C@H](C1)CC(C3)(C2)C(=O)N)NC(=O)CNC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)C
  • InChI=1S/C27H42N6O8/c1-14(2)4-18(24(40)33-27-9-16-5-17(10-27)8-26(7-16,13-27)25(28)41)32-21(36)12-29-20(35)11-30-23(39)19(6-22(37)38)31-15(3)34/h14,16-19H,4-13H2,1-3H3,(H2,28,41)(H,29,35)(H,30,39)(H,31,34)(H,32,36)(H,33,40)(H,37,38)/t16-,17+,18-,19-,26?,27?/m0/s1
  • Key:LUJZBZPLIRWWGJ-NBONATBJSA-N

Peptide 021 (Ac-DGGLAG-NH2, P021, GLXC-21260) is a synthetic peptide derivative that is derived from a 4-amino acid active fragment of ciliary neurotrophic factor, which has been substituted with an unnatural adamantane based amino acid residue on the end of the chain. This substitution is highly lipophilic and facilitates transport of the molecule across the blood-brain barrier. It has neurotrophic effects and enhances neurogenesis, and has been investigated for treatment of neurological disorders such as Alzheimer's disease.[1][2][3][4][5][6][7]

References

Related Articles

Wikiwand AI